期刊文献+

异常黑胆质成熟剂总酚与顺铂、多西他赛联用对宫颈癌HeLa细胞增殖和凋亡的影响 被引量:3

Effects of total phenolics from abnormal savda munziq combined with cisplation,ocetaxd on HeLa cells proliferation and apoptosis
下载PDF
导出
摘要 目的观察异常黑胆质成熟剂总酚(简称总酚)与顺铂、多西他赛联用对体外培养的人宫颈癌HeLa细胞增殖和凋亡的影响。方法取对数生长期HeLa细胞接种于96孔板,加入0、50、75、100、125μg/ml总酚,然后加入0.1、1、5μg/ml顺铂或5、10、20μg/ml多西他赛,培养24、48、72 h,每孔设只加相同浓度顺铂或多西他赛的对照孔和只加培养液的对照孔。用MTT法检测细胞增殖抑制率。取对数生长期的HeLa细胞接种到培养瓶中,分别加入5μg/ml顺铂、20μg/ml多西他赛、50μg/ml总酚、5μg/ml顺铂+50μg/ml总酚、20μg/ml多西他赛+50μg/ml总酚,并设对照组,培养48 h后采用流式细胞术检测细胞凋亡率,荧光倒置显微镜下观察细胞生长情况。结果用总酚联合顺铂、多西他赛培养的HeLa细胞与相同浓度顺铂、多西他赛培养者相比,细胞增殖抑制率和凋亡率更高(P均<0.05),形态学改变更明显。结论总酚与顺铂、多西他赛联用能显著抑制HeLa细胞的增殖,促进其凋亡。总酚与顺铂、多西他赛联用有协同作用。 Objective To investigate the effects of total phenolics from abnormal savda munziq combined with cisplatin or docetaxel on HeLa cell line of cervical cancer cultured in vitro.Methods HeLa cells were treated with different drug concentrations: total phenolics combined with cisplatin and total phenolics combined with docetaxel,we chose MTT assay to test the inhibiting effects and Flow cytometry to examine cell apoptosis rate.Microscope was used to observe the growth of HeLa cells.Results The inhibiting effect and apoptosis rate of total phenolics combined with cisplatin was greater than cisplatin(P0.05),this phenomenon also appeared in total phenolics combined with docetaxel.Conclusion Total phenolics from abnormal savda munziq combined with cisplatin or docetaxel can inhibit the growth of HeLa cells obviously,and induce apoptosis in vitro,the combinations have synergistic actions.
出处 《山东医药》 CAS 北大核心 2011年第22期22-24,共3页 Shandong Medical Journal
基金 国家自然科学基金资助项目(30860325)
关键词 宫颈肿瘤 宫颈癌 异常黑胆质成熟剂 总酚 顺铂 多西他赛 细胞增殖 细胞凋亡 cervical neoplasm cervical cancer abnormal savda munziq total phenolics cisplatin ocetaxel cell proliferation apoptosis
  • 相关文献

参考文献7

  • 1Eifel PJ.Concurrent chemotherapy and radiation therapy as the standard of care for cervical cancer[J].Nat Clin Pract Oncol,2006,3(5):248-255.
  • 2Darzynkiewicz Z,Halieka DH,Tanaka T.Cytometric assessment of DNA damage induced by DNA topoisomerase inhibitors[J].Methods Mol Biol,2009,58(2):145-153.
  • 3Bergqvist M,Brattstrom D,Gullbo J,et al.p53 status and its in vitro relationship to radiosensitivity and chemosensitivity in lung cancer[J].Anticancer Res,2003,23(2B):1207-1212.
  • 4王玉萍,邵斌,曹静,楚天骄,雷冬梅,郝志伟,党秋红,曾宪旭,张欢.顺铂诱导人宫颈癌Hela细胞凋亡及其对细胞周期影响的研究[J].中国妇幼保健,2006,21(21):2985-2986. 被引量:4
  • 5Hall AG,Tillby MJ.Mechanisms of action,and modes of resistance to alkylating agents used in the treatment of hematological malignancies[J].Blood Rev,1992,75(6):163-173.
  • 6彭磊,王臻,王庆良,曹云新,朱德生,张志培,吴银松,施新猷.多西紫杉醇体外诱导骨肉瘤细胞系pl-1的凋亡[J].中国临床药理学与治疗学,2002,7(1):1-4. 被引量:10
  • 7哈木拉提·吾甫尔 艾斯卡尔·依米提 伊力哈木.维医成熟、清除剂诱导人Hela细胞凋亡时P53与bcl-2基因的表达.新疆医科大学学报,2000,23(1):46-46.

二级参考文献15

  • 1徐婉,程丽坤.Egr-1基因在人宫颈癌Hela细胞中的表达及其对细胞凋亡的作用[J].哈尔滨医科大学学报,2005,39(1):14-17. 被引量:1
  • 2粟俭.药物诱导的肿瘤细胞凋亡研究进展[J].国外医学(肿瘤学分册),1995,22(1):7-10. 被引量:59
  • 3Kelland LR, Abel G.Comparative in vitro cytotoxicity of tanol and tanotere against cisplatin-sensitive and resistant human ovarian carcinoma cell lines[J]. Cancer Chemother Pharmacol, 1992;30:444-6
  • 4Riou JF, Petitqenet O,Aynie L, et al. Establishment and charalterization of docetaxel (tanotere) resistant human breast carcinoma and murine leukemic celllines[J]. Proc Am Assoc Cancer Res, 1994;35:339-41
  • 5Eastman A. Activation of programmed cell death by anticancer agents: cisplatin as a model system[J]. Cancer Cells (Cold Spring Harbor), 1990;2:275-8
  • 6Walton MI, Whysong DO, Connor PM, et al. Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin-induced apoptosis[J]. Cancer Res, 1990;53:1853-5
  • 7Lane DPA. Death in the life of p53[J]. Nature (London), 1993;362:786-8
  • 8Hanauske AR,Degen D, Hilsenbeck SG, et al. Effects of tanotere and tanol on in vitro colony formation of freshly enplanted human tumour cells[J]. Anticancer Drugs, 1992;3:121-4
  • 9duPont NC,Monk BJ.Chemotherapy in the management of cervical carcinoma.Clin Adv Hematol Oncol,2006,4 (4):279
  • 10Muggia FM.Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancer.Semi Oncol,2004,31 (6 suppl 14):1

共引文献12

同被引文献26

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部